Literature DB >> 17459484

Regulation and biological activities of the autotaxin-LPA axis.

Laurens A van Meeteren1, Wouter H Moolenaar.   

Abstract

Autotaxin (ATX), or nucleotide pyrophosphatase/phosphodiesterase 2 (NPP2), is an exo-enzyme originally identified as a tumor cell autocrine motility factor. ATX is unique among the NPPs in that it primarily functions as a lysophospholipase D, converting lysophosphatidylcholine into the lipid mediator lysophosphatidic acid (LPA). LPA acts on specific G protein-coupled receptors to elicit a wide range of cellular responses, ranging from cell proliferation and migration to neurite remodeling and cytokine production. While LPA signaling has been studied extensively over the last decade, we are only now beginning to explore the properties and biological importance of ATX as the major LPA-producing phospholipase. In this review, we highlight recent advances in our understanding of the ATX-LPA axis, giving first an update on LPA action and then focusing on ATX, in particular its regulation, its link to cancer and its vital role in vascular development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17459484     DOI: 10.1016/j.plipres.2007.02.001

Source DB:  PubMed          Journal:  Prog Lipid Res        ISSN: 0163-7827            Impact factor:   16.195


  146 in total

1.  Lysophosphatidic acid effects on atherosclerosis and thrombosis.

Authors:  Mei-Zhen Cui
Journal:  Clin Lipidol       Date:  2011-08

Review 2.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.

Authors:  Victoria A Blaho; Timothy Hla
Journal:  Chem Rev       Date:  2011-09-22       Impact factor: 60.622

3.  Depot-specific regulation of autotaxin with obesity in human adipose tissue.

Authors:  Chloé Rancoule; Rodolphe Dusaulcy; Karine Tréguer; Sandra Grès; Charlotte Guigné; Didier Quilliot; Philippe Valet; Jean Sébastien Saulnier-Blache
Journal:  J Physiol Biochem       Date:  2012-05-27       Impact factor: 4.158

Review 4.  High-fat diet, obesity and prostate disease: the ATX-LPA axis?

Authors:  Prakash Kulkarni; Robert H Getzenberg
Journal:  Nat Clin Pract Urol       Date:  2009-02-10

5.  Copy number variants in patients with short stature.

Authors:  Hermine A van Duyvenvoorde; Julian C Lui; Sarina G Kant; Wilma Oostdijk; Antoinet C J Gijsbers; Mariëtte J V Hoffer; Marcel Karperien; Marie J E Walenkamp; Cees Noordam; Paul G Voorhoeve; Verónica Mericq; Alberto M Pereira; Hedi L Claahsen-van de Grinten; Sandy A van Gool; Martijn H Breuning; Monique Losekoot; Jeffrey Baron; Claudia A L Ruivenkamp; Jan M Wit
Journal:  Eur J Hum Genet       Date:  2013-09-25       Impact factor: 4.246

Review 6.  Oxidized LDL: diversity, patterns of recognition, and pathophysiology.

Authors:  Irena Levitan; Suncica Volkov; Papasani V Subbaiah
Journal:  Antioxid Redox Signal       Date:  2010-07-01       Impact factor: 8.401

Review 7.  Bioactive lysophospholipids: role in regulation of aqueous humor outflow and intraocular pressure in the context of pathobiology and therapy of glaucoma.

Authors:  Ponugoti Vasantha Rao
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-27       Impact factor: 2.671

8.  Sp-1 and c-Myc mediate lysophosphatidic acid-induced expression of vascular endothelial growth factor in ovarian cancer cells via a hypoxia-inducible factor-1-independent mechanism.

Authors:  Yuanda Song; Jinhua Wu; Regina A Oyesanya; Zendra Lee; Abir Mukherjee; Xianjun Fang
Journal:  Clin Cancer Res       Date:  2009-01-15       Impact factor: 12.531

9.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

Review 10.  Group VIA Ca2+-independent phospholipase A2 (iPLA2beta) and its role in beta-cell programmed cell death.

Authors:  Xiaoyong Lei; Suzanne E Barbour; Sasanka Ramanadham
Journal:  Biochimie       Date:  2010-01-18       Impact factor: 4.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.